NO323312B1 - 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse - Google Patents

2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse Download PDF

Info

Publication number
NO323312B1
NO323312B1 NO20022976A NO20022976A NO323312B1 NO 323312 B1 NO323312 B1 NO 323312B1 NO 20022976 A NO20022976 A NO 20022976A NO 20022976 A NO20022976 A NO 20022976A NO 323312 B1 NO323312 B1 NO 323312B1
Authority
NO
Norway
Prior art keywords
oxo
indol
acetamide
chlorobenzyl
methyl
Prior art date
Application number
NO20022976A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022976D0 (no
NO20022976L (no
Inventor
Nicoletta Pescalli
Ernesto Menta
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of NO20022976D0 publication Critical patent/NO20022976D0/no
Publication of NO20022976L publication Critical patent/NO20022976L/no
Publication of NO323312B1 publication Critical patent/NO323312B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022976A 1999-12-23 2002-06-20 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse NO323312B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
PCT/EP2000/013068 WO2001047916A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity

Publications (3)

Publication Number Publication Date
NO20022976D0 NO20022976D0 (no) 2002-06-20
NO20022976L NO20022976L (no) 2002-06-20
NO323312B1 true NO323312B1 (no) 2007-03-12

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022976A NO323312B1 (no) 1999-12-23 2002-06-20 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse

Country Status (24)

Country Link
US (1) US6753342B2 (de)
EP (1) EP1244652B1 (de)
JP (1) JP2003519140A (de)
KR (1) KR100795533B1 (de)
CN (1) CN1250542C (de)
AT (1) ATE302772T1 (de)
AU (1) AU776332B2 (de)
BR (1) BR0016553A (de)
CA (1) CA2395205A1 (de)
CZ (1) CZ20022170A3 (de)
DE (1) DE60022227T2 (de)
EA (1) EA004925B1 (de)
ES (1) ES2246918T3 (de)
HU (1) HUP0203524A3 (de)
IL (2) IL150329A0 (de)
IT (1) IT1315267B1 (de)
MX (1) MXPA02006217A (de)
NO (1) NO323312B1 (de)
NZ (1) NZ519689A (de)
PL (1) PL356541A1 (de)
SK (1) SK285682B6 (de)
TR (1) TR200201613T2 (de)
WO (1) WO2001047916A1 (de)
ZA (1) ZA200204964B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1076657T3 (da) 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
IT1318641B1 (it) 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same
SG146624A1 (en) 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
RU2376286C2 (ru) * 2004-03-11 2009-12-20 Актелион Фармасьютиклз Лтд Производные индол-1-илуксусной кислоты
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
JP5420395B2 (ja) 2006-04-07 2014-02-19 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｐ結合カセット輸送体の調節剤
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
WO2008019357A2 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
RU2569678C2 (ru) 2010-04-22 2015-11-27 Вертекс Фармасьютикалз Инкорпорейтед Способ получения циклоалкилкарбоксамидо-индольных соединений
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
WO2012135027A2 (en) * 2011-03-25 2012-10-04 The Research Foundation Of State University Of New York Thiolactone antibiotics
AU2013290444B2 (en) 2012-07-16 2018-04-26 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
PL3925607T5 (pl) 2014-04-15 2026-06-01 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0841924T3 (da) * 1995-08-02 2003-02-10 Univ Newcastle Ventures Ltd Benzimidazolforbindelser
CO4970714A1 (es) * 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DK1076657T3 (da) * 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling

Also Published As

Publication number Publication date
TR200201613T2 (tr) 2002-10-21
MXPA02006217A (es) 2004-02-26
IL150329A0 (en) 2002-12-01
EP1244652B1 (de) 2005-08-24
NO20022976D0 (no) 2002-06-20
IL150329A (en) 2006-07-05
WO2001047916A1 (en) 2001-07-05
CZ20022170A3 (cs) 2002-09-11
US20030158153A1 (en) 2003-08-21
CA2395205A1 (en) 2001-07-05
ES2246918T3 (es) 2006-03-01
CN1413205A (zh) 2003-04-23
ATE302772T1 (de) 2005-09-15
IT1315267B1 (it) 2003-02-03
DE60022227D1 (de) 2005-09-29
HUP0203524A3 (en) 2008-01-28
DE60022227T2 (de) 2006-06-22
SK285682B6 (sk) 2007-06-07
EA200200558A1 (ru) 2002-12-26
KR100795533B1 (ko) 2008-01-16
NO20022976L (no) 2002-06-20
EA004925B1 (ru) 2004-10-28
EP1244652A1 (de) 2002-10-02
ZA200204964B (en) 2004-01-29
BR0016553A (pt) 2002-09-17
HUP0203524A2 (hu) 2003-03-28
JP2003519140A (ja) 2003-06-17
ITMI992693A0 (it) 1999-12-23
PL356541A1 (en) 2004-06-28
ITMI992693A1 (it) 2001-06-23
SK8962002A3 (en) 2002-11-06
CN1250542C (zh) 2006-04-12
AU2170401A (en) 2001-07-09
US6753342B2 (en) 2004-06-22
AU776332B2 (en) 2004-09-02
KR20020063247A (ko) 2002-08-01
NZ519689A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
AU638510B2 (en) Indole derivatives
US5057614A (en) Substituted pyrroles
EP1244652B1 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
KR100295128B1 (ko) 인돌로일구아니딘유도체
AU671836B2 (en) Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
JP2006511600A (ja) ４−置換ベンズイミダゾールおよび該化合物の胃液分泌抑制剤としての使用
EP3027602A1 (de) Neuartige indol- und pyrrolderivate, verfahren zur herstellung davon und pharmazeutische zusammensetzungen damit
WO1995014690A1 (en) Morpholine derivatives as dopamine receptor subtype ligands
AU675641B2 (en) Imidazole, triazole and tetrazole derivatives
AU782920B2 (en) Substituted pyrroles
AU2006307907A1 (en) Novel indole-containing beta agonists, method for producing them and their use as drugs
US4482714A (en) Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives
US4515949A (en) [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees